               SEQUENCE LISTING

<110> Brightpulse Holding LTD

<120> PROTEIN FOR USE IN THE TREATMENT OF OCULAR DISEASES

<160> 2

<170> BiSSAP 1.0

<210> 1
<211> 81
<212> PRT
<213> Homo sapiens

<220> 
<221> SOURCE
<222> 1..81
<223> /mol_type="protein"
      /organism="Homo sapiens"

<400> 1
Leu Lys Cys Tyr Thr Cys Lys Glu Pro Met Thr Ser Ala Ser Cys Arg 
1               5                   10                   15    
Thr Ile Thr Arg Cys Lys Pro Glu Asp Thr Ala Cys Met Thr Thr Leu 
            20                   25                  30        
Val Thr Val Glu Ala Glu Tyr Pro Phe Asn Gln Ser Pro Val Val Thr 
        35                   40                  45            
Arg Ser Cys Ser Ser Ser Cys Val Ala Thr Asp Pro Asp Ser Ile Gly 
    50                   55                  60                
Ala Ala His Leu Ile Phe Cys Cys Phe Arg Asp Leu Cys Asn Ser Glu 
65                   70                  75                  80
Leu 
    

<210> 2
<211> 103
<212> PRT
<213> Homo sapiens

<220> 
<221> SOURCE
<222> 1..103
<223> /mol_type="protein"
      /organism="Homo sapiens"

<400> 2
Met Ala Ser Arg Trp Ala Val Gln Leu Leu Leu Val Ala Ala Trp Ser 
1               5                   10                   15    
Met Gly Cys Gly Glu Ala Leu Lys Cys Tyr Thr Cys Lys Glu Pro Met 
            20                   25                  30        
Thr Ser Ala Ser Cys Arg Thr Ile Thr Arg Cys Lys Pro Glu Asp Thr 
        35                   40                  45            
Ala Cys Met Thr Thr Leu Val Thr Val Glu Ala Glu Tyr Pro Phe Asn 
    50                   55                  60                
Gln Ser Pro Val Val Thr Arg Ser Cys Ser Ser Ser Cys Val Ala Thr 
65                   70                  75                  80
Asp Pro Asp Ser Ile Gly Ala Ala His Leu Ile Phe Cys Cys Phe Arg 
                85                   90                  95    
Asp Leu Cys Asn Ser Glu Leu 
            100            

